Index
Every molecule we review, A–Z.
The full Aminoscope desk in one list — peptides, GLP-1 medications, and longevity compounds. Each entry links to its evidence-first monograph: what the human data actually shows, and where the marketing runs ahead of it.
A
- AcarboseApproved diabetes drug; extends mouse lifespan (male-skewed) in the ITP. · Longevity
- AdipotideFat-targeting peptide; worked in monkeys, but damaged their kidneys. · Peptides
- Calcium AKG (Ca-AKG)TCA metabolite; mouse morbidity-compression, overstated 'younger' headline. · Longevity
- Alpha-GPCCholinergic nootropic; dementia-era data + an unresolved stroke-risk signal. · Longevity
- 5-Amino-1MQNNMT inhibitor; elegant mechanism, no human trials. · Peptides
- AmycretinGLP-1 + amylin co-agonist, oral and injectable; early Phase 1 signal. · GLP-1
- AnastrozoleAromatase inhibitor; raises T in men but off-label and risks bone. · Longevity
- AOD-9604The 'Anti-Obesity Drug' fragment; safe in trials, but failed to beat placebo. · Peptides
- ApigeninChamomile flavonoid; sleep + CD38/NAD⁺ angle, mostly preclinical or via chamomile. · Longevity
- ARA-290 (Cibinetide)EPO-derived innate-repair peptide; small neuropathy trials, investigational. · Peptides
- Astragalus (TA-65)Telomerase activator; cell/animal hype, small industry-linked human data. · Longevity
B
C
- CagrilintideLong-acting amylin analog; the other half of CagriSema, real Phase 2 weight loss. · GLP-1
- CagriSemaCagrilintide + semaglutide; the REDEFINE program. · GLP-1
- CerebrolysinPorcine-brain peptide mixture; weak, mixed evidence, not FDA-approved. · Longevity
- CJC-1295 & IpamorelinGH secretagogue peptides. · Peptides
- CoQ10Mitochondrial cofactor; real heart-failure data (Q-SYMBIO), anti-aging use is hype. · Longevity
D
E
- EcnoglutidecAMP-biased weekly GLP-1 agonist; Phase 3 in China, investigational in the US. · GLP-1
- EnclomipheneRestores testosterone while preserving fertility. · Longevity
- EpitalonTelomerase/longevity claims vs the evidence. · Longevity
- ErgothioneineDiet-derived antioxidant 'longevity vitamin'; strong associations, no outcome RCTs. · Longevity
F
G
- GHK-CuCopper peptide for skin and hair. · Peptides
- GHRP-2Ghrelin-receptor GH secretagogue; real GH release but cortisol/prolactin + tolerance, no long-term outcomes. · Peptides
- GHRP-6The 'hunger' GH secretagogue; strong appetite effect, real short-term GH pharmacology, no long-term outcomes. · Peptides
- GlutathioneMaster antioxidant; oral raises stores, IV is hype, longevity unproven. · Longevity
- GlyNACGlycine + NAC to rebuild glutathione; promising but unreplicated. · Longevity
- GonadorelinSynthetic GnRH; real pulsatile-fertility data, but its bolus TRT-adjunct use is unproven. · Longevity
- Gotu kola (Centella)Best human data is for venous insufficiency, not the brain claims. · Longevity
H
I
K
L
- LarazotideOral tight-junction ('leaky gut') peptide; celiac Phase 3 missed its primary endpoint. · Peptides
- Lithium orotateLow-dose lithium supplement; intriguing water-lithium epidemiology, no orotate RCTs. · Longevity
- LL-37Human cathelicidin; real antimicrobial biology, preclinical-only + a double-edged inflammatory side. · Peptides
M
- MazdutideGLP-1/glucagon dual agonist; approved in China, investigational in the US. · GLP-1
- Melanotan IITanning/libido injectable; unapproved, with documented harms. · Peptides
- MetforminThe longevity-drug candidate — TAME and MILES. · Longevity
- Methylene blueA real drug, not a supplement; hormetic, with a serotonin-syndrome risk. · Longevity
- MK-677 (Ibutamoren)Oral ghrelin mimetic; raises IGF-1, not outcomes. · Peptides
- MOTS-cMitochondrial peptide; real biology, no human data. · Longevity
N
O
P
- P21 (P021)CNTF-derived neurogenic peptide; rodent cognition data only, no human trials, muddled P21/P021 identity. · Peptides
- ParaxanthineCaffeine's main metabolite; promising but small, industry-funded trials. · Longevity
- PemvidutideGLP-1/glucagon dual agonist aimed at preserving lean mass; Phase 2. · GLP-1
- Pentadeca ArginateBPC-157 'successor' (PDA); near-empty direct evidence — benefits extrapolated from BPC-157. · Peptides
- PhosphatidylserineOlder bovine-PS cognition data; the soy form sold today is weaker. · Longevity
- PQQMitochondrial-biogenesis quinone; strong mechanism, small/short human trials. · Longevity
- PT-141 (Bremelanotide)FDA-approved for libido; research-popular. · Peptides
Q
R
S
- SelankNon-benzodiazepine anxiolytic peptide. · Peptides
- SemaglutideWegovy/Ozempic; the benchmark GLP-1. · GLP-1
- SemaxRussian nootropic peptide; raises BDNF. · Peptides
- SermorelinA real GHRH drug vs the anti-aging pitch. · Peptides
- ShilajitMineral-rich resin; a few small studies, a real purity problem. · Longevity
- SLU-PP-332ERR-agonist 'exercise mimetic'; rodent and in-vitro only, no human data. · Longevity
- SpermidineAutophagy inducer; great story, null RCT. · Longevity
- SS-31 (Elamipretide)Mitochondria-targeting peptide; strong mechanism, mostly mixed trials. · Longevity
- SulforaphaneBroccoli-sprout Nrf2 activator; real RCTs in niches, not aging. · Longevity
- SurvodutideGLP-1/glucagon dual agonist for obesity and MASH; Phase 3 ongoing. · GLP-1
T
- TaurineThe Singh 2023 Science work and the human data. · Longevity
- TB-500 (Thymosin β4)Real dry-eye trials; recovery use untested. · Peptides
- Tesamorelin (Egrifta)FDA-approved GHRH analog. · Peptides
- TesofensineStriking Phase 2 weight loss, with an asterisk. · Peptides
- Testosterone therapy (TRT)FDA-approved for hypogonadism; proven, but often mis-sold for anti-aging. · Longevity
- ThymalinThymic Khavinson bioregulator; longevity claims from unreplicated Russian research. · Peptides
- Thymosin α1Approved immune drug abroad (Zadaxin); not the anti-aging injectable. · Peptides
- TirzepatideMounjaro/Zepbound; dual GIP+GLP-1. · GLP-1
- TUDCABile-acid chaperone; real liver biology, but its ALS program failed phase 3. · Longevity